DRUGOME
LIVE

Serial Number

88397912

Owner

SUMITOMO PHARMA CO., LTD.

Attorney

B. Brett Heavner

Filing Date

Apr 23, 2019

Add to watchlist:

No watchlists yet
View on USPTO

DRUGOME Trademark

Serial Number: 88397912 • Registration: 6083085

DRUGOME is a trademark filed by SUMITOMO PHARMA CO., LTD. on April 23, 2019. The trademark is classified under Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

SUMITOMO PHARMA CO., LTD. (102 trademarks)

6-8, DOSHOMACHI 2-CHOME, CHUO-KU
OSAKA-SHI, OSAKA 541-0045 , JP

Entity Type: 03

ROIVANT SCIENCES GMBH (70 trademarks)

VIADUKTSTRASSE 8
BASEL 4051 , CH

Entity Type: 27

SUMITOVANT BIOPHARMA, INC. (3 trademarks)

NEW YORK, NY 10018

Entity Type: 03

Trademark Details

Filing Date

April 23, 2019

Registration Date

June 23, 2020

Published for Opposition

April 7, 2020

Goods & Services

Downloadable computer software for providing, analyzing and generating reports; downloadable computer software for data processing; downloadable computer software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and/or transmission of data, images and information; downloadable computer software for the conversion, analysis, processing, storage and transmission of artificial intelligence; downloadable computer software for database integration; downloadable computer software for creating searchable databases of information and data; downloadable software for analytics in the fields of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, and for clinical trial and post-market trial data; downloadable computer software featuring electronic computer databases of pharmaceuticals, biomedical research, and for clinical trial and post-market trial data; downloadable computer search engine software for compiling, accessing and providing updated scientific, medical, pharmaceutical and clinical information, and news information of general interest

Financial analysis; financial consulting; financial valuations and forecasting; financial analysis, namely, compiling and analyzing statistics and data; financial analysis of investments in pharmaceutical and biomedical research and development, and clinical and post-market trials; financial evaluation, tracking, analysis, forecasting, consultancy, advisory and research services relating to healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, and clinical and post-market trials

Advertising; business management; business administration; office functions; business research services in the field of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, clinical trials, and post-market data; business information services; market research; provision of market research information; data processing services; analysis of business data; business analysis and statistical analysis of healthcare data, pharmaceuticals, biomedical research, and for clinical trial and post-market data; systematization and compilation of data in computer databases, in particular compilation of information into computer databases for research and analysis purposes in the field of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, clinical trials and post-market data; professional business analysis and consultancy and statistical analysis in the fields of healthcare, pharmaceuticals, biomedicine, clinical trials, epidemiological research, pharmacoepidemiological research, post-market trials and research evaluating epidemiological outcomes

Scientific and technological services, namely, scientific research and analysis in the field of pharmaceuticals and biomedicine; analysis of technical data by computers; pharmaceutical, biomedical, biological therapeutic research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical and biopharmaceutical research and development; providing scientific research information in the field of pharmaceuticals, biomedicine, clinical trials and post-market trials; cloud computing featuring software for conducing scientific research and analysis in the fields of public health, healthcare, pharmaceutical and biomedical research, clinical trial data and data from examinations carried out after the introduction of medicines on the market; providing temporary use of online non-downloadable computer software featuring electronic computer databases of pharmaceuticals, biomedicine, pharmaceutical and biopharmaceutical research and development, medical information, clinical trial and post-market trial data; providing temporary use of online non-downloadable computer software for research in the field of pharmaceuticals and biopharmaceuticals; providing temporary use of online non-downloadable computer software for compiling, accessing, controlling, managing and providing updated scientific, pharmaceutical, medical and clinical information, and news information of general interest; Artificial intelligence and machine learning statistical analysis, consultancy and reporting for pharmaceutical and biomedical research; information of general interest; providing temporary use of non-downloadable software applications accessible via a web site for data analytics, financial analytics and risk management for use in the fields of pharmaceutical and biomedical research and development, clinical trials, and the provision of medical and healthcare services

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 23, 2025 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 24, 2024 ASGN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 6, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 6, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 6, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 6, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 6, 2022 COAR
REGISTERED-PRINCIPAL REGISTER
Jun 23, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 7, 2020 NPUB
PUBLISHED FOR OPPOSITION
Apr 7, 2020 PUBO
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Mar 25, 2020 ASCK
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 18, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 3, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 25, 2020 XAEC
ASSIGNED TO LIE
Feb 25, 2020 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 25, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 25, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 25, 2020 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 10, 2020 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Feb 4, 2020 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 21, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 11, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 11, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 11, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 11, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jun 11, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jun 11, 2019 CNRT
ASSIGNED TO EXAMINER
Jun 3, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 8, 2019 NWOS
NEW APPLICATION ENTERED
Apr 26, 2019 NWAP